Fusion Expression of Human β-Defensin DEFB113 and Its Biological Activities

董靖,于合国,刁华,郭晨云,林东海

DOI: https://doi.org/10.19526/j.cnki.1005-8915.2012.01.001

2012-01-01

Abstract:DEFB113 is a recently identified human β-defensin, while its biological functions remain unclear. With the purpose of providing a low-cost and high-yielding approach to express DEFB113 for the determination of its bioactivities, the sequence encoding the mature peptide of DEFB113 was inserted into pTWIN1 and the recombinant transformed vector into E. coli BL21 (DE3) for the recombinant expression. Most of the fusion proteins were expressed in a soluble form. Moreover, the chitin-binding domain (CBD) and the intein in the fusion tag facilitated the affinity chromatography and the auto-cleavage of the fusion tag, respectively. The resulting DEFB113 peptide was produced with a yield of 6.4 mg/L LB. The purified DEFB113 peptide exhibited potent antimicrobial activities against E. coli, S. aureus and C. albicans. In addition, the recombinant DEFB113 peptide caused little if any hemolysis towards human erythrocytes. In this respect, DEFB113 might exist as a promising peptide antibiotic. These attempts have laid the basis for further study on the physiological roles of DEFB113 as well as on the structure-function relationships of other DEFBs.